Intelligence / Services / Auditor Changes / Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc.
1 Oct 2026: Auditor resigned (SEC 8-K) · Baker Tilly US, LLP → Baker Tilly. Recorded in the SEC EDGAR full-text search.
- Filed
- 1 Oct 2026
- Ticker
- VVOS
- Sector
- Medical devices
- Sic
- 3841
- Items
- 4.01, 9.01
- Location
- Littleton, CO
- State
- Colorado
- Country
- United States
- SEC CIK
- 1716166
- Reference
- 0001493152-26-045193
- Former
- Baker Tilly US, LLP
- Engaged
- Baker Tilly
- Event
- Auditor resigned or declined to stand
A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.
- Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
- 22 added in the 30 days to 19 Nov 2026.
Find the decision makers at Vivos Therapeutics, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.
Across AOS Research
Other records for Vivos Therapeutics, Inc. in our registers.
More in Auditor resigned or declined to stand
Auditor Changes
Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.